Pharma Focus Asia

Novel Phoenix® Therapy Developed to Treat PTSD

Evren Technologies developed Phoenix®, a novel therapy for the treatment of Post-traumatic Stress Disorder (PTSD).

The Phoenix® is an earbud device which delivers a light electrical tingle to activate vagus nerve consisting of a calming effect on the body and also helps in reducing the symptoms of PTSD.

The device helps in delivering transcutaneous auricular vagal nerve stimulation (taVNS) in a discreet earbud design.

Phoenix earbud device provides personalized medicine by addressing underlying autonomic imbalance of PTSD by bringing transcutaneous auricular vagal nerve stimulation (taVNS) in a closed-loop system.

Phoenix® - Revolutionary Transcutaneous Auricular Vagus Nerve Therapy has granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) to treat Post-traumatic Stress Disorder (PTSD).

Annually 7.5 million Americans undergo treatment for PTSD. Moreover, due to COVID shutdown PTSD rates have tripled.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024